UC San Diego Researchers Develop Non-Hormonal Hydrogel Treatment for Menopausal Vaginal Symptoms
核心洞察
University of California San Diego scientists have developed a novel hydrogel (搜索) biomaterial that may provide hormone-free treatment for genitourinary syndrome of menopause (搜索), which affects up to 85% of women over 40.
The extracellular matrix (搜索)-based hydrogel (搜索) demonstrated effectiveness in preclinical studies, restoring vaginal tissue structure and increasing smooth muscle thickness in menopausal rat models after 14 days of treatment.
This breakthrough addresses a significant unmet medical need, as 65% of women with GSM (搜索) report dissatisfaction with current treatments, offering an alternative to estrogen therapy for patients who cannot or prefer not to use hormonal treatments.
Scientists at the University of California San Diego have developed a promising non-hormonal hydrogel (搜索) treatment that could revolutionize care for millions of women experiencing genitourinary syndrome of menopause (搜索) (GSM (搜索)). The research, published in Advanced Materials, presents a novel biomaterial approach to addressing vaginal dryness (搜索) and pain that affects up to 85% of women over 40 years of age.
"We have developed a new material, which was designed specifically for the vagina," said Karen Christman, professor in the Shu Chien-Gene Lay Department of Bioengineering and the Sanford Stem Cell Institute at UC San Diego (搜索) and one of the senior authors on the paper.
Addressing a Major Public Health Challenge
Genitourinary syndrome of menopause (搜索) represents a significant healthcare burden, with 30% to 60% of affected women suffering from vaginal dryness (搜索) and pain. The condition severely impacts quality of life, interfering with sleep, sexual activity, and daily activities including travel, exercise, and socializing. Despite the prevalence of GSM (搜索), current treatment options fall short of patient needs, with 65% of women reporting dissatisfaction with available prescription and over-the-counter treatments.
"An estimated 47 million women in the U.S. become menopausal every year, thus GSM (搜索) represents a major public health issue that urgently needs investment," said Dr. Marianna Alperin, professor and vice chair for Translational Research in the Department of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego (搜索).
Limitations of Current Treatments
The hormonal changes following menopause (搜索) cause extensive tissue alterations, including thinning of vaginal tissues, shrinkage of blood vessels, and reduction in connective tissue and smooth muscle layers that support vaginal function and pelvic organs. Additionally, immune cells in the female reproductive tract undergo changes that lead to inflammatory protein production.
While low-dose vaginal estrogen therapy remains the gold-standard treatment for GSM (搜索) and effectively thickens the vaginal lining, it has significant limitations. The treatment does not address deeper smooth muscle tissue responsible for vaginal structure and function. Furthermore, patient and clinician concerns about potential hormone-sensitive cancer risks, combined with high costs and limited insurance coverage, create barriers to widespread adoption.
Novel Hydrogel Technology
The UC San Diego (搜索) research team leveraged expertise in biomaterial development to create hydrogels from natural tissue scaffolding, known as the extracellular matrix (搜索). Christman's laboratory has previously demonstrated success with similar hydrogel (搜索) technologies for cardiac muscle healing after heart attacks, with these cardiac applications successfully completing Phase 1 FDA-approved clinical trials.
"We are not looking to replace estrogen treatments," explained Emma Zelus, the first author of the study and current preclinical research manager at the Sanford Stem Cell Institute. "We want to provide an alternative for patients and physicians who either do not want to use hormone-based therapy or for women for whom vaginal estrogen alone is insufficient."
Preclinical Study Results
The research team conducted a randomized study using 24 menopausal rats to evaluate the hydrogel (搜索)'s effectiveness. Animals received daily topical intravaginal applications of either hydrogel at two concentrations (6 or 8 milligrams per milliliter), collagen, or saline for 14 days.
The results demonstrated significant therapeutic potential. Vaginal tissues in hydrogel (搜索)-treated rats appeared closer to those of pre-menopausal animals, with notable increases in smooth muscle thickness. The 8 milligram dose showed superior effectiveness, likely due to higher concentrations of extracellular matrix (搜索) proteins.
Importantly, tissue analysis revealed that the hydrogel (搜索) penetrated beyond surface layers to reach the muscular layer of the vaginal wall. The treatment triggered beneficial immune responses, particularly increasing macrophages associated with tissue repair. No safety concerns or adverse effects were observed during the study period.
Future Development Plans
The research team has outlined comprehensive next steps for advancing this technology toward clinical application. Plans include testing various hydrogel (搜索) concentrations in larger preclinical studies over extended timeframes. Researchers also aim to optimize dosing frequency, investigating whether the treatment can be administered two to three times weekly rather than daily.
"We need a multidisciplinary approach to solving women's health issues," emphasized Dr. Alperin, who serves as a urogynecology and reconstructive pelvic surgery specialist at UC San Diego (搜索) Health.
The research received support from the NIH National Institute on Aging (搜索) and the NIH National Institute of Child Health and Human Development (搜索). Notably, Christman serves as a cofounder of Ventrix Bio Inc (搜索)., which is commercializing similar hydrogel (搜索) technology for cardiac applications, suggesting potential pathways for clinical translation of this women's health innovation.